A Clinical Trial of Imipramine (“Tofranil”) on Depressed Patients

Publisher Website
Google Scholar
Abstract
Recently many new anti-depressive drugs have flooded the market, the objective being initially to assist and finally to replace E.C.T. as the treatment of choice for depressive states. One such preparation is Tofranil (N-(γ-Dimethyl-aminopropyl)-iminodibenzyl hydrochloride or imipramine). It was first favourably reported on by Azima (1) and Kuhn (2).

This publication has 1 reference indexed in Scilit: